Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer

传染病和癌症疫苗和免疫疗法培训补助金

基本信息

  • 批准号:
    10465086
  • 负责人:
  • 金额:
    $ 16.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Summary This is a new application that proposes a training program for 3 graduate students and 2 postdoctoral fellows in vaccines and immunotherapies against microbial pathogens and cancer. The rationale for this application is to capitalize on the long-term experience of TJU in the area of vaccines, therapeutics and cancer, the need for a such a unique training opportunity in Philadelphia, and the opportunity to develop a “holistic” training experience in both basic and applied aspects of viral and tumor immunity. An important characteristic of the TPVIIDC is that the diversity of research interests of the 21 preceptors affords an opportunity to provide a comprehensive training experience that integrates basic science, vaccine development and therapeutics. Whereas there are other training programs in cancer immunology or vaccines against infectious diseases there is historically little cross-talk between these highly related research areas. We feel strongly that our program will help to provide better training by providing opportunities in different but related areas of immunology of cancer and infectious diseases. While the students and fellows will spend the majority of their time in their host laboratory, ancillary opportunities will enable interaction with a wide range of the participating faculty, facilitated by shared seminars, retreats and course offerings.
总结 这是一个新的应用程序,提出了一个培训计划,为3名研究生和2名 在疫苗和免疫疗法方面的博士后研究员对微生物病原体和癌症。 这种应用的基本原理是利用TJU在该领域的长期经验 疫苗,治疗和癌症,需要这样一个独特的培训机会, 费城,并有机会发展一个“整体”的培训经验,在基础和 病毒和肿瘤免疫的应用方面。TPVIIDC的一个重要特点是, 21位导师的研究兴趣各不相同, 综合培训经验,将基础科学、疫苗开发和 治疗学尽管有其他癌症免疫学或疫苗的培训项目, 对抗传染病,历史上这些高度相关的 研究领域。我们强烈认为,我们的计划将有助于提供更好的培训, 在不同但相关的癌症和传染病免疫学领域提供机会 疾病而学生和研究员将花大部分时间在他们的主机 实验室,辅助机会将使互动与广泛的参与 教师,通过共享研讨会,务虚会和课程提供便利。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Oral D-mannose treatment suppresses experimental autoimmune encephalomyelitis via induction of regulatory T cells.
  • DOI:
    10.1016/j.jneuroim.2021.577778
  • 发表时间:
    2022-01-15
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Hwang D;Boehm A;Rostami A;Zhang GX;Ciric B
  • 通讯作者:
    Ciric B
GATA1 controls numbers of hematopoietic progenitors and their response to autoimmune neuroinflammation.
  • DOI:
    10.1182/bloodadvances.2022008234
  • 发表时间:
    2022-12-13
  • 期刊:
  • 影响因子:
    7.5
  • 作者:
    Hwang, Daniel;Ishikawa, Larissa Lumi Watanabe;Seyedsadr, Maryam S.;Mari, Elisabeth;Kasimoglu, Ezgi;Sahin, Ziver;Boehm, Alexandra;Jang, Soohwa;Rasouli, Javad;Vaccaro, Courtney;Gonzalez, Michael;Hakonarson, Hakon;Rostami, Abdolmohamad;Zhang, Guang-Xian;Ciric, Bogoljub
  • 通讯作者:
    Ciric, Bogoljub
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthias Johannes Schnell其他文献

High Seroprevalence of Antibodies to Avian Influenza Viruses among Wild Waterfowl in Alaska: Implications for Surveillance
阿拉斯加野生水禽中禽流感病毒抗体的高血清阳性率:对监测的影响
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    H. Wilson;Jeffery S. Hall;P. Flint;J. Christian Franson;C. Ely;J. Schmutz;M. D. Samuel;Matthias Johannes Schnell
  • 通讯作者:
    Matthias Johannes Schnell

Matthias Johannes Schnell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthias Johannes Schnell', 18)}}的其他基金

Toward a protective Covid-19 vaccine utilizing an established vector platform
利用已建立的载体平台开发保护性 Covid-19 疫苗
  • 批准号:
    10170820
  • 财政年份:
    2020
  • 资助金额:
    $ 16.49万
  • 项目类别:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
泛狂犬病病毒疗法和抗狂犬病病毒的保护机制
  • 批准号:
    10078258
  • 财政年份:
    2020
  • 资助金额:
    $ 16.49万
  • 项目类别:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
泛狂犬病病毒疗法和抗狂犬病病毒的保护机制
  • 批准号:
    10311511
  • 财政年份:
    2020
  • 资助金额:
    $ 16.49万
  • 项目类别:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
泛狂犬病病毒疗法和抗狂犬病病毒的保护机制
  • 批准号:
    9905663
  • 财政年份:
    2020
  • 资助金额:
    $ 16.49万
  • 项目类别:
Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer
传染病和癌症疫苗和免疫疗法培训补助金
  • 批准号:
    10201425
  • 财政年份:
    2018
  • 资助金额:
    $ 16.49万
  • 项目类别:
Development of a single-dose rabies virus vaccine
单剂量狂犬病病毒疫苗的研制
  • 批准号:
    10054163
  • 财政年份:
    2016
  • 资助金额:
    $ 16.49万
  • 项目类别:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
多价灭活丝状病毒/狂犬病疫苗的临床前表征
  • 批准号:
    8790424
  • 财政年份:
    2013
  • 资助金额:
    $ 16.49万
  • 项目类别:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
多价灭活丝状病毒/狂犬病疫苗的临床前表征
  • 批准号:
    9205480
  • 财政年份:
    2013
  • 资助金额:
    $ 16.49万
  • 项目类别:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
多价灭活丝状病毒/狂犬病疫苗的临床前表征
  • 批准号:
    8994257
  • 财政年份:
    2013
  • 资助金额:
    $ 16.49万
  • 项目类别:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
多价灭活丝状病毒/狂犬病疫苗的临床前表征
  • 批准号:
    8496399
  • 财政年份:
    2013
  • 资助金额:
    $ 16.49万
  • 项目类别:

相似海外基金

Collaborative Research: Implementation Grant: Active Societal Participation In Research and Education
合作研究:实施补助金:社会积极参与研究和教育
  • 批准号:
    2326774
  • 财政年份:
    2024
  • 资助金额:
    $ 16.49万
  • 项目类别:
    Continuing Grant
Planning Grant: Developing capacity to attract diverse students to the geosciences: A public relations framework
规划补助金:培养吸引多元化学生学习地球科学的能力:公共关系框架
  • 批准号:
    2326816
  • 财政年份:
    2024
  • 资助金额:
    $ 16.49万
  • 项目类别:
    Standard Grant
Travel: NSF Student Travel Grant for 2024 ACM/IEEE International Conference on Software Engineering
旅行:2024 年 ACM/IEEE 软件工程国际会议 NSF 学生旅行补助金
  • 批准号:
    2413092
  • 财政年份:
    2024
  • 资助金额:
    $ 16.49万
  • 项目类别:
    Standard Grant
Conference: Travel Grant for the 28th Annual International Conference on Research in Computational Molecular Biology (RECOMB 2024)
会议:第 28 届计算分子生物学研究国际会议 (RECOMB 2024) 旅费补助
  • 批准号:
    2414575
  • 财政年份:
    2024
  • 资助金额:
    $ 16.49万
  • 项目类别:
    Standard Grant
Research Infrastructure: KCV EDGE (Equitable and Diverse Grant Ecosystem)
研究基础设施:KCV EDGE(公平且多样化的资助生态系统)
  • 批准号:
    2345142
  • 财政年份:
    2024
  • 资助金额:
    $ 16.49万
  • 项目类别:
    Cooperative Agreement
Doctoral Dissertation Research Improvement Grant: Biobanking, Epistemic Infrastructure, and the Lifecycle of Genomic Data
博士论文研究改进补助金:生物样本库、认知基础设施和基因组数据的生命周期
  • 批准号:
    2341622
  • 财政年份:
    2024
  • 资助金额:
    $ 16.49万
  • 项目类别:
    Standard Grant
Nuclear Physics Consolidated Grant
核物理综合拨款
  • 批准号:
    ST/Y000277/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.49万
  • 项目类别:
    Research Grant
Planning grant Increasing geoscience graduate student diversity in Tennessee's flagship state university
规划拨款增加田纳西州旗舰州立大学地球科学研究生的多样性
  • 批准号:
    2326716
  • 财政年份:
    2024
  • 资助金额:
    $ 16.49万
  • 项目类别:
    Standard Grant
Collaborative Research: Implementation Grant: Active Societal Participation In Research and Education
合作研究:实施补助金:社会积极参与研究和教育
  • 批准号:
    2326775
  • 财政年份:
    2024
  • 资助金额:
    $ 16.49万
  • 项目类别:
    Continuing Grant
Travel Grant: Workshop on Impacts of Unusual Weather Events and Climate Anomalies on a Tropical Rainforest
旅行补助金:异常天气事件和气候异常对热带雨林的影响研讨会
  • 批准号:
    2340946
  • 财政年份:
    2024
  • 资助金额:
    $ 16.49万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了